Catalyst Wire Dossier Catalyst Wire Dossier

AxoGuard Nerve Cap

· Axogen Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AxoGuard Nerve Cap, covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain [NA]

See pricing